Your browser doesn't support javascript.
loading
Aggressive Progression in Glioblastoma Cells through Potentiated Activation of Integrin α5ß1 by the Tenascin-C-Derived Peptide TNIIIA2.
Fujita, Motomichi; Yamamoto, Tetsuya; Iyoda, Takuya; Fujisawa, Tatsuya; Sasada, Manabu; Nagai, Reo; Kudo, Chikako; Otsuka, Kazuki; Kamiya, Sadahiro; Kodama, Hiroaki; Fukai, Fumio.
Afiliação
  • Fujita M; Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
  • Yamamoto T; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan.
  • Iyoda T; Department of Pharmacy, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, Sanyo-Onoda, Yamaguchi, Japan.
  • Fujisawa T; Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
  • Sasada M; Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
  • Nagai R; Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
  • Kudo C; Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
  • Otsuka K; Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
  • Kamiya S; Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Josai International University, Togane-shi, Chiba, Japan.
  • Kodama H; Faculty of Science and Engineering, Saga University, Saga, Japan.
  • Fukai F; Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan. fukai@rs.noda.tus.ac.jp.
Mol Cancer Ther ; 18(9): 1649-1658, 2019 09.
Article em En | MEDLINE | ID: mdl-31189613

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Peptídeos / Glioblastoma / Tenascina / Ensaios Antitumorais Modelo de Xenoenxerto / Integrina alfa5beta1 Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Peptídeos / Glioblastoma / Tenascina / Ensaios Antitumorais Modelo de Xenoenxerto / Integrina alfa5beta1 Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão